Related Experiment Videos
Influence of ACE inhibition on left ventricular hypertrophy
1Cattedra di Semeiotica e Terapia Medica, University of Brescia, Italy.
Insights
Reversing left ventricular hypertrophy (LVH) in hypertensive patients significantly lowers cardiovascular event risk. Failure to decrease or increased left ventricular mass indicates a higher risk, underscoring the importance of complete LVH reversal.
Area of Science:
- Cardiology
- Hypertension Research
- Clinical Medicine
Background:
- Hypertension is a major risk factor for cardiovascular disease.
- Left ventricular hypertrophy (LVH) is a common cardiac adaptation to hypertension.
- The clinical impact of LVH regression on cardiovascular outcomes requires further investigation.
Purpose of the Study:
- To evaluate the association between changes in left ventricular mass after antihypertensive treatment and cardiovascular events.
- To determine if complete reversal of LVH influences cardiovascular risk in hypertensive patients.
Main Methods:
- Analysis of cardiovascular events in hypertensive patients undergoing antihypertensive treatment.
- Assessment of left ventricular mass changes post-treatment.
- Correlation of LVH status (no decrease, increase, or reversal) with event rates.
Main Results:
- A lack of decrease or an increase in left ventricular mass was linked to a higher risk of cardiovascular events.
- Complete reversal of LVH was associated with a significant reduction in cardiovascular events, nearing normalization.
- Further studies are needed to fully assess the clinical impact of LVH reversal.
Conclusions:
- Antihypertensive treatment aiming for complete left ventricular hypertrophy reversal may significantly reduce cardiovascular risk.
- Monitoring left ventricular mass changes is crucial for risk stratification in hypertensive patients.
- Complete LVH reversal appears to normalize cardiovascular event risk in hypertensive individuals.
Abstract:
Further studies are needed to assess the true clinical impact, in terms of reduced morbidity and mortality, of reversed LVH in hypertensive patients. However, the initial results strongly indicate that either a lack of decrease or an increase in left ventricular mass after antihypertensive treatment is associated with a higher risk of cardiovascular events, the latter being significantly reduced and almost normalised by a complete reversal of LVH.